ArticleNPJ breast cancer2026

Preoperative onapristone-XR in postmenopausal women with progesterone receptor-positive (PgR+)/HER2-negative early breast cancer: SOLTI-1802 ONAWA trial results.

Meritxell Bellet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.